English | Español

Regulatory
+ Regulatory
Amanda Rupp | Jun 1, 2016

NCHC applauds hospital readmissions policy changes
Vimbai Chikomo | Jun 1, 2016

HHS 'knowingly circumvented Congress and undermined the Constitution,' Basic Health Program probe reveals
+ Regulatory
Amanda Rupp | Jun 1, 2016

CHMP gives positive opinion of Zepatier tablet
+ Community
Amanda Rupp | Jun 1, 2016

FDA approves Zinbryta to treat MS
Kim Sunderland | Jun 1, 2016

Independent Women’s Forum policy expert says more diverse health insurance plans are needed across U.S.
+ Technology/Innovation
Amanda Rupp | Jun 1, 2016

FDA approves new diagnostic imaging agent for recurrent prostate cancer
+ Community
Amanda Rupp | Jun 1, 2016

Bristol-Myers Squibb responds to ICER report
+ Regulatory
Amanda Rupp | Jun 1, 2016

First buprenorphine implant treatment for opioid dependence earns FDA approval

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation